Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

✍ Scribed by Steinman, Lawrence; Kappos, Ludwig; Comi, Giancarlo; Panitch, Hillel; Oger, Joel; Antel, Jack; Conlon, Paul; Comi, Giancarlo; Kappos, Ludwig; Oger, Joel; Panitch, Hillel; Rae-Grant, Alexander; Castaldo, John; Eckert, Nancy; Guarnaccia, Joseph B.; Mills, Pamela; Johnson, Gary; Calabresi, Peter A.; Pozzilli, Carlo; Bastianello, Stefano; Giugni, Elisabetta; Witjas, Tatiana; Cozzone, Patrick; Pelletier, Jean; Pöhlau, Dieter; Przuntek, Horst; Hoffmann, Volker; Bever, Christopher; Katz, Eleanor; Clanet, Michel; Berry, Isabelle; Brassat, David; Brunet, Irene; Edan, Gilles; Duquette, Pierre; Radue, Ernst-Wilhelm; Schött, Dagmar; Lienert, Carmen; Taksaoui, Alice; Rodegher, M.; Filippi, M.; Evans, Alan; Bourgouin, Pierre; Zijdenbos, Alex; Salem, Shawki; Ling, Nicholas; Alleva, David; Johnson, Eric; Gaur, Amitabh; Crowe, Paul; Liu, Xin-Jun

• Book ID: 109829237
• Publisher: Nature Publishing Group
• Year: 2000
• Tongue: English
• Weight: 133 KB
• Volume: 6
• Category: Article
• ISSN: 1078-8956
• DOI: 10.1038/80525